nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.648	1	CbGaD
Trifluoperazine—S100A4—embryo—polycystic ovary syndrome	0.00438	0.0342	CbGeAlD
Trifluoperazine—EBPL—adipose tissue—polycystic ovary syndrome	0.00366	0.0285	CbGeAlD
Trifluoperazine—S100A4—adrenal cortex—polycystic ovary syndrome	0.00359	0.028	CbGeAlD
Trifluoperazine—EBP—uterus—polycystic ovary syndrome	0.00359	0.028	CbGeAlD
Trifluoperazine—CALY—pituitary gland—polycystic ovary syndrome	0.00336	0.0262	CbGeAlD
Trifluoperazine—EBPL—adrenal gland—polycystic ovary syndrome	0.00328	0.0256	CbGeAlD
Trifluoperazine—S100A4—endometrium—polycystic ovary syndrome	0.00321	0.025	CbGeAlD
Trifluoperazine—EBPL—female gonad—polycystic ovary syndrome	0.00306	0.0239	CbGeAlD
Trifluoperazine—CYP1A2—urine—polycystic ovary syndrome	0.00303	0.0236	CbGeAlD
Trifluoperazine—TNNC1—adrenal cortex—polycystic ovary syndrome	0.00302	0.0236	CbGeAlD
Trifluoperazine—S100A4—uterus—polycystic ovary syndrome	0.00296	0.023	CbGeAlD
Trifluoperazine—S100A4—pituitary gland—polycystic ovary syndrome	0.0029	0.0226	CbGeAlD
Trifluoperazine—S100A4—adipose tissue—polycystic ovary syndrome	0.00289	0.0225	CbGeAlD
Trifluoperazine—EBPL—endocrine gland—polycystic ovary syndrome	0.00285	0.0222	CbGeAlD
Trifluoperazine—EBP—endocrine gland—polycystic ovary syndrome	0.00273	0.0213	CbGeAlD
Trifluoperazine—TNNC1—endometrium—polycystic ovary syndrome	0.0027	0.021	CbGeAlD
Trifluoperazine—CALY—endocrine gland—polycystic ovary syndrome	0.0026	0.0203	CbGeAlD
Trifluoperazine—S100A4—adrenal gland—polycystic ovary syndrome	0.00259	0.0202	CbGeAlD
Trifluoperazine—TNNC1—pituitary gland—polycystic ovary syndrome	0.00244	0.019	CbGeAlD
Trifluoperazine—TNNC1—adipose tissue—polycystic ovary syndrome	0.00243	0.019	CbGeAlD
Trifluoperazine—S100A4—female gonad—polycystic ovary syndrome	0.00242	0.0189	CbGeAlD
Trifluoperazine—S100A4—vagina—polycystic ovary syndrome	0.0024	0.0187	CbGeAlD
Trifluoperazine—HTR2A—urine—polycystic ovary syndrome	0.00237	0.0185	CbGeAlD
Trifluoperazine—S100A4—endocrine gland—polycystic ovary syndrome	0.00225	0.0175	CbGeAlD
Trifluoperazine—TNNC1—adrenal gland—polycystic ovary syndrome	0.00218	0.017	CbGeAlD
Trifluoperazine—XDH—endometrium—polycystic ovary syndrome	0.00205	0.016	CbGeAlD
Trifluoperazine—UGT1A4—endocrine gland—polycystic ovary syndrome	0.00197	0.0154	CbGeAlD
Trifluoperazine—XDH—vagina—polycystic ovary syndrome	0.00154	0.012	CbGeAlD
Trifluoperazine—XDH—endocrine gland—polycystic ovary syndrome	0.00144	0.0112	CbGeAlD
Trifluoperazine—CALM3—adrenal cortex—polycystic ovary syndrome	0.00132	0.0103	CbGeAlD
Trifluoperazine—CALM2—embryo—polycystic ovary syndrome	0.00126	0.00984	CbGeAlD
Trifluoperazine—CALM1—embryo—polycystic ovary syndrome	0.00126	0.00979	CbGeAlD
Trifluoperazine—SIGMAR1—adrenal cortex—polycystic ovary syndrome	0.00118	0.00918	CbGeAlD
Trifluoperazine—CALM3—endometrium—polycystic ovary syndrome	0.00118	0.00917	CbGeAlD
Trifluoperazine—CALM3—uterus—polycystic ovary syndrome	0.00108	0.00845	CbGeAlD
Trifluoperazine—CALM3—pituitary gland—polycystic ovary syndrome	0.00106	0.0083	CbGeAlD
Trifluoperazine—CALM3—adipose tissue—polycystic ovary syndrome	0.00106	0.00826	CbGeAlD
Trifluoperazine—SIGMAR1—endometrium—polycystic ovary syndrome	0.00105	0.00819	CbGeAlD
Trifluoperazine—CALM2—adrenal cortex—polycystic ovary syndrome	0.00103	0.00806	CbGeAlD
Trifluoperazine—CALM1—adrenal cortex—polycystic ovary syndrome	0.00103	0.00802	CbGeAlD
Trifluoperazine—SIGMAR1—uterus—polycystic ovary syndrome	0.000968	0.00755	CbGeAlD
Trifluoperazine—SIGMAR1—pituitary gland—polycystic ovary syndrome	0.000951	0.00741	CbGeAlD
Trifluoperazine—CALM3—adrenal gland—polycystic ovary syndrome	0.000951	0.00741	CbGeAlD
Trifluoperazine—SIGMAR1—adipose tissue—polycystic ovary syndrome	0.000947	0.00738	CbGeAlD
Trifluoperazine—CALM2—endometrium—polycystic ovary syndrome	0.000923	0.0072	CbGeAlD
Trifluoperazine—CALM1—endometrium—polycystic ovary syndrome	0.000919	0.00717	CbGeAlD
Trifluoperazine—CALM3—female gonad—polycystic ovary syndrome	0.000886	0.00691	CbGeAlD
Trifluoperazine—CALM3—vagina—polycystic ovary syndrome	0.000881	0.00687	CbGeAlD
Trifluoperazine—CALM2—uterus—polycystic ovary syndrome	0.000851	0.00663	CbGeAlD
Trifluoperazine—SIGMAR1—adrenal gland—polycystic ovary syndrome	0.00085	0.00662	CbGeAlD
Trifluoperazine—CALM1—uterus—polycystic ovary syndrome	0.000847	0.0066	CbGeAlD
Trifluoperazine—CALM2—pituitary gland—polycystic ovary syndrome	0.000836	0.00651	CbGeAlD
Trifluoperazine—CALM2—adipose tissue—polycystic ovary syndrome	0.000832	0.00649	CbGeAlD
Trifluoperazine—CALM1—pituitary gland—polycystic ovary syndrome	0.000832	0.00648	CbGeAlD
Trifluoperazine—CALM1—adipose tissue—polycystic ovary syndrome	0.000828	0.00646	CbGeAlD
Trifluoperazine—CHRM2—endocrine gland—polycystic ovary syndrome	0.000812	0.00633	CbGeAlD
Trifluoperazine—SIGMAR1—female gonad—polycystic ovary syndrome	0.000792	0.00618	CbGeAlD
Trifluoperazine—SIGMAR1—vagina—polycystic ovary syndrome	0.000787	0.00614	CbGeAlD
Trifluoperazine—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000781	0.00609	CbGeAlD
Trifluoperazine—DRD2—pituitary gland—polycystic ovary syndrome	0.000768	0.00599	CbGeAlD
Trifluoperazine—HTR2A—embryo—polycystic ovary syndrome	0.000765	0.00597	CbGeAlD
Trifluoperazine—HTR1A—adrenal gland—polycystic ovary syndrome	0.000759	0.00592	CbGeAlD
Trifluoperazine—CALM2—adrenal gland—polycystic ovary syndrome	0.000746	0.00582	CbGeAlD
Trifluoperazine—CALM1—adrenal gland—polycystic ovary syndrome	0.000743	0.00579	CbGeAlD
Trifluoperazine—ADRA1A—adrenal gland—polycystic ovary syndrome	0.0007	0.00546	CbGeAlD
Trifluoperazine—CALM2—female gonad—polycystic ovary syndrome	0.000696	0.00543	CbGeAlD
Trifluoperazine—CALM1—female gonad—polycystic ovary syndrome	0.000693	0.0054	CbGeAlD
Trifluoperazine—CALM2—vagina—polycystic ovary syndrome	0.000692	0.00539	CbGeAlD
Trifluoperazine—CALM1—vagina—polycystic ovary syndrome	0.000689	0.00537	CbGeAlD
Trifluoperazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.000685	0.0708	CrCbGaD
Trifluoperazine—HRH1—endometrium—polycystic ovary syndrome	0.00067	0.00523	CbGeAlD
Trifluoperazine—HTR1A—endocrine gland—polycystic ovary syndrome	0.000659	0.00513	CbGeAlD
Trifluoperazine—CALM2—endocrine gland—polycystic ovary syndrome	0.000647	0.00505	CbGeAlD
Trifluoperazine—CALM1—endocrine gland—polycystic ovary syndrome	0.000644	0.00502	CbGeAlD
Trifluoperazine—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000607	0.00473	CbGeAlD
Trifluoperazine—HRH1—adipose tissue—polycystic ovary syndrome	0.000604	0.00471	CbGeAlD
Trifluoperazine—DRD2—endocrine gland—polycystic ovary syndrome	0.000595	0.00464	CbGeAlD
Trifluoperazine—Flupentixol—ADRA1A—polycystic ovary syndrome	0.000588	0.0608	CrCbGaD
Trifluoperazine—HRH1—adrenal gland—polycystic ovary syndrome	0.000542	0.00423	CbGeAlD
Trifluoperazine—HTR2A—pituitary gland—polycystic ovary syndrome	0.000507	0.00395	CbGeAlD
Trifluoperazine—HRH1—female gonad—polycystic ovary syndrome	0.000505	0.00394	CbGeAlD
Trifluoperazine—HRH1—vagina—polycystic ovary syndrome	0.000502	0.00392	CbGeAlD
Trifluoperazine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000502	0.00391	CbGeAlD
Trifluoperazine—ABCB1—embryo—polycystic ovary syndrome	0.000501	0.00391	CbGeAlD
Trifluoperazine—Nefazodone—ADRA1B—polycystic ovary syndrome	0.000488	0.0505	CrCbGaD
Trifluoperazine—HRH1—endocrine gland—polycystic ovary syndrome	0.00047	0.00366	CbGeAlD
Trifluoperazine—HTR2A—adrenal gland—polycystic ovary syndrome	0.000453	0.00353	CbGeAlD
Trifluoperazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.00044	0.0455	CrCbGaD
Trifluoperazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.00043	0.0445	CrCbGaD
Trifluoperazine—HTR2A—vagina—polycystic ovary syndrome	0.000419	0.00327	CbGeAlD
Trifluoperazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.000412	0.0426	CrCbGaD
Trifluoperazine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000411	0.0032	CbGeAlD
Trifluoperazine—HTR2A—endocrine gland—polycystic ovary syndrome	0.000393	0.00306	CbGeAlD
Trifluoperazine—ABCB1—endometrium—polycystic ovary syndrome	0.000367	0.00286	CbGeAlD
Trifluoperazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.000352	0.0364	CrCbGaD
Trifluoperazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.000352	0.0364	CrCbGaD
Trifluoperazine—ABCB1—uterus—polycystic ovary syndrome	0.000338	0.00264	CbGeAlD
Trifluoperazine—Quetiapine—ADRA1D—polycystic ovary syndrome	0.000332	0.0344	CrCbGaD
Trifluoperazine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000332	0.00259	CbGeAlD
Trifluoperazine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000331	0.00258	CbGeAlD
Trifluoperazine—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.00033	0.0342	CrCbGaD
Trifluoperazine—Nefazodone—ADRA1A—polycystic ovary syndrome	0.000328	0.034	CrCbGaD
Trifluoperazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.000315	0.0326	CrCbGaD
Trifluoperazine—Promazine—ADRA1D—polycystic ovary syndrome	0.000305	0.0316	CrCbGaD
Trifluoperazine—Trazodone—ADRA1A—polycystic ovary syndrome	0.000304	0.0314	CrCbGaD
Trifluoperazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.000301	0.0311	CrCbGaD
Trifluoperazine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000297	0.00231	CbGeAlD
Trifluoperazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.000296	0.0306	CrCbGaD
Trifluoperazine—Loxapine—ADRA1B—polycystic ovary syndrome	0.00029	0.03	CrCbGaD
Trifluoperazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.000289	0.0299	CrCbGaD
Trifluoperazine—Quetiapine—ADRA1B—polycystic ovary syndrome	0.000283	0.0293	CrCbGaD
Trifluoperazine—ABCB1—female gonad—polycystic ovary syndrome	0.000277	0.00216	CbGeAlD
Trifluoperazine—ABCB1—vagina—polycystic ovary syndrome	0.000275	0.00214	CbGeAlD
Trifluoperazine—Promazine—ADRA1B—polycystic ovary syndrome	0.000261	0.027	CrCbGaD
Trifluoperazine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000257	0.00201	CbGeAlD
Trifluoperazine—Clozapine—ADRA1B—polycystic ovary syndrome	0.000244	0.0252	CrCbGaD
Trifluoperazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.000237	0.0245	CrCbGaD
Trifluoperazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.000229	0.0237	CrCbGaD
Trifluoperazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.000212	0.0219	CrCbGaD
Trifluoperazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.000202	0.0209	CrCbGaD
Trifluoperazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.000199	0.0206	CrCbGaD
Trifluoperazine—Loxapine—ADRA1A—polycystic ovary syndrome	0.000196	0.0202	CrCbGaD
Trifluoperazine—Quetiapine—ADRA1A—polycystic ovary syndrome	0.000191	0.0197	CrCbGaD
Trifluoperazine—Promazine—ADRA1A—polycystic ovary syndrome	0.000175	0.0181	CrCbGaD
Trifluoperazine—Clozapine—ADRA1A—polycystic ovary syndrome	0.000164	0.017	CrCbGaD
Trifluoperazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.000154	0.016	CrCbGaD
Trifluoperazine—Clozapine—CYP1A1—polycystic ovary syndrome	8.37e-05	0.00866	CrCbGaD
Trifluoperazine—HTR6—Signaling Pathways—IGF1—polycystic ovary syndrome	8.43e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT2—polycystic ovary syndrome	8.43e-06	3.95e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.38e-06	3.92e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—VEGFA—polycystic ovary syndrome	8.34e-06	3.91e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—VEGFA—polycystic ovary syndrome	8.34e-06	3.91e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	8.33e-06	3.9e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.33e-06	3.9e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ATF1—polycystic ovary syndrome	8.31e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ATF1—polycystic ovary syndrome	8.31e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MTHFR—polycystic ovary syndrome	8.31e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.31e-06	3.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CRP—polycystic ovary syndrome	8.28e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IRS2—polycystic ovary syndrome	8.28e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CRP—polycystic ovary syndrome	8.28e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IRS2—polycystic ovary syndrome	8.28e-06	3.88e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GNAS—polycystic ovary syndrome	8.27e-06	3.87e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	8.18e-06	3.83e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.15e-06	3.82e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.11e-06	3.8e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.11e-06	3.8e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.06e-06	3.78e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MTHFR—polycystic ovary syndrome	8.04e-06	3.77e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MTHFR—polycystic ovary syndrome	8.04e-06	3.77e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	8.03e-06	3.76e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.01e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GNAS—polycystic ovary syndrome	8e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GNAS—polycystic ovary syndrome	8e-06	3.75e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.93e-06	3.72e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NGFR—polycystic ovary syndrome	7.93e-06	3.71e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.92e-06	3.71e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	7.91e-06	3.71e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IRS2—polycystic ovary syndrome	7.91e-06	3.7e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—POMC—polycystic ovary syndrome	7.88e-06	3.69e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—NCOR1—polycystic ovary syndrome	7.88e-06	3.69e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PRL—polycystic ovary syndrome	7.86e-06	3.68e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.79e-06	3.65e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.79e-06	3.65e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.77e-06	3.64e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.77e-06	3.64e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.72e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	7.71e-06	3.61e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	7.68e-06	3.6e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—TH—polycystic ovary syndrome	7.68e-06	3.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NGFR—polycystic ovary syndrome	7.67e-06	3.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NGFR—polycystic ovary syndrome	7.67e-06	3.59e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.67e-06	3.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IRS2—polycystic ovary syndrome	7.65e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IRS2—polycystic ovary syndrome	7.65e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	7.65e-06	3.58e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.63e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—POMC—polycystic ovary syndrome	7.62e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—POMC—polycystic ovary syndrome	7.62e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NCOR1—polycystic ovary syndrome	7.62e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NCOR1—polycystic ovary syndrome	7.62e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.62e-06	3.57e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PRL—polycystic ovary syndrome	7.6e-06	3.56e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PRL—polycystic ovary syndrome	7.6e-06	3.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.57e-06	3.55e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.56e-06	3.54e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	7.56e-06	3.54e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	7.52e-06	3.52e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IRS1—polycystic ovary syndrome	7.48e-06	3.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—CYP1A1—polycystic ovary syndrome	7.47e-06	3.5e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.47e-06	3.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.46e-06	3.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.33e-06	3.43e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.33e-06	3.43e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IRS1—polycystic ovary syndrome	7.23e-06	3.39e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IRS1—polycystic ovary syndrome	7.23e-06	3.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CYP1A1—polycystic ovary syndrome	7.22e-06	3.38e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CYP1A1—polycystic ovary syndrome	7.22e-06	3.38e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.21e-06	3.38e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.21e-06	3.38e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.19e-06	3.37e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.08e-06	3.32e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.02e-06	3.29e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—MTHFR—polycystic ovary syndrome	6.96e-06	3.26e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT2—polycystic ovary syndrome	6.92e-06	3.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GNAS—polycystic ovary syndrome	6.91e-06	3.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IRS1—polycystic ovary syndrome	6.9e-06	3.23e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	6.78e-06	3.17e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.74e-06	3.16e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—MTHFR—polycystic ovary syndrome	6.73e-06	3.15e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—MTHFR—polycystic ovary syndrome	6.73e-06	3.15e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	6.71e-06	3.14e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT2—polycystic ovary syndrome	6.69e-06	3.14e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT2—polycystic ovary syndrome	6.69e-06	3.14e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GNAS—polycystic ovary syndrome	6.69e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GNAS—polycystic ovary syndrome	6.69e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IRS1—polycystic ovary syndrome	6.68e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IRS1—polycystic ovary syndrome	6.68e-06	3.13e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.67e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.66e-06	3.12e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	6.63e-06	3.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—INS—polycystic ovary syndrome	6.61e-06	3.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.59e-06	3.08e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	6.55e-06	3.07e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.53e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	6.53e-06	3.06e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	6.51e-06	3.05e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	6.49e-06	3.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NRG1—polycystic ovary syndrome	6.46e-06	3.03e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	6.46e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	6.45e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	6.45e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	6.42e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	6.41e-06	3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—INS—polycystic ovary syndrome	6.39e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—INS—polycystic ovary syndrome	6.39e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	6.39e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT2—polycystic ovary syndrome	6.39e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.37e-06	2.98e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.37e-06	2.98e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.27e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NRG1—polycystic ovary syndrome	6.25e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.25e-06	2.93e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.24e-06	2.92e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.24e-06	2.92e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	6.21e-06	2.91e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	6.21e-06	2.91e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT2—polycystic ovary syndrome	6.18e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT2—polycystic ovary syndrome	6.18e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	6.13e-06	2.87e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—SERPINE1—polycystic ovary syndrome	6.07e-06	2.84e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—BCL2—polycystic ovary syndrome	6.05e-06	2.83e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.97e-06	2.8e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.96e-06	2.79e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.93e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	5.92e-06	2.77e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.9e-06	2.76e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—SERPINE1—polycystic ovary syndrome	5.87e-06	2.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—SERPINE1—polycystic ovary syndrome	5.87e-06	2.75e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—BCL2—polycystic ovary syndrome	5.85e-06	2.74e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—BCL2—polycystic ovary syndrome	5.85e-06	2.74e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.82e-06	2.73e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.81e-06	2.72e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	5.72e-06	2.68e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.7e-06	2.67e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	5.7e-06	2.67e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	5.67e-06	2.65e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.66e-06	2.65e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PPARG—polycystic ovary syndrome	5.64e-06	2.64e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	5.61e-06	2.63e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.6e-06	2.62e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	5.6e-06	2.62e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	5.58e-06	2.61e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—POMC—polycystic ovary syndrome	5.57e-06	2.61e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	5.56e-06	2.61e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IRS2—polycystic ovary syndrome	5.54e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—INS—polycystic ovary syndrome	5.54e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.51e-06	2.58e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	5.51e-06	2.58e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	5.49e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	5.48e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	5.48e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	5.48e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	5.46e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PPARG—polycystic ovary syndrome	5.46e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PPARG—polycystic ovary syndrome	5.46e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—LEP—polycystic ovary syndrome	5.42e-06	2.54e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.39e-06	2.53e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.39e-06	2.52e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—POMC—polycystic ovary syndrome	5.39e-06	2.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—POMC—polycystic ovary syndrome	5.39e-06	2.52e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.38e-06	2.52e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.38e-06	2.52e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—polycystic ovary syndrome	5.37e-06	2.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IRS2—polycystic ovary syndrome	5.36e-06	2.51e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.36e-06	2.51e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—INS—polycystic ovary syndrome	5.36e-06	2.51e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—INS—polycystic ovary syndrome	5.36e-06	2.51e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	5.3e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	5.29e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.28e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.28e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.28e-06	2.47e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—LEP—polycystic ovary syndrome	5.24e-06	2.45e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—LEP—polycystic ovary syndrome	5.24e-06	2.45e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.21e-06	2.44e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—polycystic ovary syndrome	5.2e-06	2.43e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—polycystic ovary syndrome	5.2e-06	2.43e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.12e-06	2.4e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.11e-06	2.39e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.03e-06	2.36e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.02e-06	2.35e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5e-06	2.34e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IRS1—polycystic ovary syndrome	4.83e-06	2.26e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.77e-06	2.24e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.77e-06	2.23e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	4.75e-06	2.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IRS1—polycystic ovary syndrome	4.68e-06	2.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.68e-06	2.19e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—POMC—polycystic ovary syndrome	4.65e-06	2.18e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—INS—polycystic ovary syndrome	4.63e-06	2.17e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.52e-06	2.12e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—POMC—polycystic ovary syndrome	4.5e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—POMC—polycystic ovary syndrome	4.5e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—INS—polycystic ovary syndrome	4.48e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—INS—polycystic ovary syndrome	4.48e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1—polycystic ovary syndrome	4.48e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT2—polycystic ovary syndrome	4.47e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1—polycystic ovary syndrome	4.33e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.33e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT2—polycystic ovary syndrome	4.33e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.33e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.28e-06	2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.25e-06	1.99e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.22e-06	1.98e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.21e-06	1.97e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.2e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.19e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.12e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.12e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.11e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.11e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.08e-06	1.91e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.06e-06	1.9e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.05e-06	1.9e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.04e-06	1.89e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	3.81e-06	1.78e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.58e-06	1.68e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.52e-06	1.65e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.52e-06	1.65e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.46e-06	1.62e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.45e-06	1.62e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—polycystic ovary syndrome	3.42e-06	1.6e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.41e-06	1.6e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.37e-06	1.58e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.35e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.31e-06	1.55e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—polycystic ovary syndrome	3.31e-06	1.55e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—polycystic ovary syndrome	3.13e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—polycystic ovary syndrome	3.03e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—polycystic ovary syndrome	3.03e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.92e-06	1.37e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—polycystic ovary syndrome	2.89e-06	1.35e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.83e-06	1.32e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.83e-06	1.32e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.82e-06	1.32e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	2.81e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—polycystic ovary syndrome	2.79e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—polycystic ovary syndrome	2.79e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	2.48e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.44e-06	1.14e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	2.43e-06	1.14e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.39e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.39e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—polycystic ovary syndrome	2.02e-06	9.47e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.96e-06	9.16e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—polycystic ovary syndrome	1.96e-06	9.16e-06	CbGpPWpGaD
